Impact of oral care prior to HSCT on the severity and clinical outcomes of oral mucositis

Clinical Transplantation

Volumn 25, Issue 2, 2011, Pages 325-328

  Da Silva Santos, Paulo Sérgio ^a   Coracin, Fábio Luiz ^a   Barros, José Carlos De Almeida ^b   Dulley, Frederico Luiz ^a   Nunes, Fábio Daumas ^a   Magalhães, Marina Gallottini ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Santa Casa School of Medicine   (Brazil)

Author keywords

Dental care; Hematopoietic stem cell transplantation; Oral mucositis; Prevention

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; MELPHALAN; METHOTREXATE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DENTAL CARE; DISEASE SEVERITY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; MOUTH HYGIENE; MOUTH MUCOSA; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RATING SCALE;

HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; NURSING ASSESSMENT; ORAL HEALTH; QUALITY ASSURANCE, HEALTH CARE; SEVERITY OF ILLNESS INDEX; STOMATITIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 79953331731     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01283.x     Document Type: Article

References (18)

1. Horowitz MM, Oster G, Fuchs H. Oral Mucositis Assessment Scale (OMAS) as a predictor of clinical and economic outcomes in bone marrow transplant patients. Blood 1999: 94(Suppl 1): 399a.
2. Sonis ST, Oster G, Fuchs H et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 2001: 19: 2001.
3. Duncan M, Grant G. Review article: oral and intestinal mucositis - causes and possible treatments. Aliment Pharmacol Ther 2003: 18: 853.
4. Sonis ST. The pathobiology of mucositis. Nat Rev Cancer 2004: 4: 277.
5. Köstler WJ, Hejna M, Wenzel C, Zielinski CC. Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment. CA Cancer J Clin 2001: 51: 290.
6. Schubert MM, Williams BE, Lloid ME, Donaldson G, Chapko MK. Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Cancer 1992: 69: 2469.
7. Treister N, Woo SB. Chemotherapy-induced oral mucositis. Available at: (accessed February 10, 2005).
8. Wardley AM, Jayson GC, Swindel R et al. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haematopoietic progenitor rescue. Br J Haematol 2000: 110: 292.
9. Aslan Ö, ÖZtürk Ü, Bulut Z, Arpaci F, ÖZet A. Oral care in bone marrow transplanted patients who develop mucositis. Bone Marrow Transplant 2003: 31(Suppl 1): S280.
10. Hwang WY, Koh LP, Ng HJ et al. A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2004: 34: 51.
11. McGuire DB, Correa ME, Johnson J, Wienandts P. The role of basic oral care and good clinical practice principles in the management of oral mucositis. Support Care Cancer 2006: 14: 541.
12. Melkos AB, Massenkeil G, Arnold R, Reichart PA. Dental treatment prior to stem cell transplantation and its influence on the posttransplantation outcome. Clin Oral Invest 2003: 7: 113.
13. Clarkson JE, Worthington HV, Eden OB. Interventions for preventing oral mucositis for patients with cancer receiving treatment (Cochrane Review). Cochrane Libr 2003: 3: CD000978.
14. Borowski B, Benhamou E, Pico JL, Laplanche A, Margainaud JP, Hayat M. Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomised controlled trial comparing two protocols of dental care. Eur J Cancer B Oral Oncol 1994: 30B: 93.
15. Shieh SH, Wang ST, Tsai ST, Tseng CC. Mouth care for nasopharyngeal cancer patients undergoing radiotherapy. Oral Oncol 1997: 33: 36.
16. Clarkson JE, Worthington HV, Eden OB. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev 2007: 18: CD001973.
17. Migliorati CA, Oberle-Edwards L, Schubert MM. The role of alternative and natural agents, cryotherapy, and/or laser for management of alimentary mucositis. Support Care Cancer 2006: 14: 533.
18. Antunes HS, Azevedo AM, Bouzas LF et al. Low-power laser in the prevention of induced oral mucositis in bone marrow transplantation patients: a randomized trial. Blood 2007: 109: 2250.